Free Trial

This company has been marked as potentially delisted and may not be actively trading.

(TMH) (TMH) Competitors

(TMH) logo

TMH vs. DGX, LH, DVA, CHE, CRVL, AMED, MD, AMN, and CCRN

Should you be buying (TMH) stock or one of its competitors? The main competitors of (TMH) include Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), and Cross Country Healthcare (CCRN). These companies are all part of the "health care services" industry.

(TMH) vs.

Quest Diagnostics (NYSE:DGX) and (TMH) (NYSE:TMH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation.

Quest Diagnostics currently has a consensus price target of $185.07, suggesting a potential upside of 3.99%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Quest Diagnostics is more favorable than (TMH).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.69
(TMH)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

88.1% of Quest Diagnostics shares are owned by institutional investors. 8.2% of Quest Diagnostics shares are owned by insiders. Comparatively, 1.3% of (TMH) shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Quest Diagnostics has a net margin of 8.80% compared to (TMH)'s net margin of 0.00%. Quest Diagnostics' return on equity of 15.07% beat (TMH)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics8.80% 15.07% 6.72%
(TMH) N/A N/A N/A

Quest Diagnostics received 97 more outperform votes than (TMH) when rated by MarketBeat users. However, 74.01% of users gave (TMH) an outperform vote while only 49.14% of users gave Quest Diagnostics an outperform vote.

CompanyUnderperformOutperform
Quest DiagnosticsOutperform Votes
544
49.14%
Underperform Votes
563
50.86%
(TMH)Outperform Votes
447
74.01%
Underperform Votes
157
25.99%

Quest Diagnostics has higher revenue and earnings than (TMH).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$10.16B1.96$871M$7.9122.50
(TMH)N/AN/AN/AN/AN/A

In the previous week, Quest Diagnostics had 21 more articles in the media than (TMH). MarketBeat recorded 22 mentions for Quest Diagnostics and 1 mentions for (TMH). Quest Diagnostics' average media sentiment score of 1.18 beat (TMH)'s score of 0.00 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
14 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
(TMH)
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Quest Diagnostics beats (TMH) on 13 of the 14 factors compared between the two stocks.

Get (TMH) News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMH vs. The Competition

Metric(TMH) Industry SectorNYSE Exchange
Market CapN/A$2.72B$2.46B$19.21B
Dividend YieldN/A13.15%13.16%4.01%
P/E RatioN/A11.2510.9633.50
Price / SalesN/A2,184,334.563,514,204.8629.16
Price / CashN/A17.2759.3917.52
Price / BookN/A3.123.424.55
Net IncomeN/A$38.79M-$333.59M$1.02B

(TMH) Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMH
(TMH)
N/A$51.84
+0.4%
N/AN/A$0.00N/A0.00N/A
DGX
Quest Diagnostics
4.6486 of 5 stars
$175.92
+1.4%
$183.73
+4.4%
+29.5%$19.63B$10.16B22.8849,000Short Interest ↑
Positive News
LH
Laboratory Co. of America
4.4421 of 5 stars
$228.54
+2.0%
$268.77
+17.6%
+23.1%$19.12B$13.01B25.9175,500Earnings Report
Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
Positive News
DVA
DaVita
4.2754 of 5 stars
$139.64
+0.5%
$166.33
+19.1%
+4.8%$11.17B$12.82B13.0070,000News Coverage
Positive News
CHE
Chemed
4.5972 of 5 stars
$546.34
-6.7%
$667.00
+22.1%
+2.5%$7.98B$2.43B27.6114,200News Coverage
Positive News
High Trading Volume
CRVL
CorVel
0.9714 of 5 stars
$111.17
-3.0%
N/A+38.6%$5.71B$871.31M65.394,230News Coverage
Positive News
High Trading Volume
AMED
Amedisys
2.9457 of 5 stars
$94.27
+0.7%
$100.75
+6.9%
+4.3%$3.09B$2.35B37.4120,000Positive News
MD
Pediatrix Medical Group
2.0354 of 5 stars
$12.50
+1.9%
$16.75
+34.0%
+38.7%$1.07B$2.01B-10.427,850Upcoming Earnings
AMN
AMN Healthcare Services
4.265 of 5 stars
$18.60
+2.4%
$38.67
+107.9%
-64.3%$710.32M$2.98B-4.834,230Upcoming Earnings
Analyst Revision
News Coverage
CCRN
Cross Country Healthcare
3.6274 of 5 stars
$13.94
-0.4%
$18.41
+32.0%
-18.4%$457.41M$1.34B-278.742,700Upcoming Earnings
Analyst Forecast
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:TMH) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners